There has been an explosion of digital health innovation in clinical trials. The Rock Health Consulting team explores this evolution and what the next horizon will bring to clinical trials.
In a world of on-demand everything the biopharma R&D cycle is an anomaly: drugs require an average of 10 to 15 years to progress from discovery to FDA approval, and an average investment of $2.6 billion across the development lifecycle. Never has that lengthy process been felt so acutely than when the world waited on edge while academic institutions, government agencies, and pharmaceutical companies raced to develop a COVID-19 vaccine in record time.
